Disease-Modifying Therapies (DMTs): clinical trials recruiting now

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions being studied

Recruiting trials involving Disease-Modifying Therapies (DMTs)

• The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
  NCT06796504 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 60 Years · Sex: All (male and female) · 9 locations

Common questions

How many recruiting trials involve Disease-Modifying Therapies (DMTs)?

1 recruiting trial across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.